John J Greisch
CIK 1278569 · Executive Chair · last filed 2026-04-17
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
HRC price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
PALM BEACH GARDENS, FL 33418
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CARR | Director | 35,417 | $53.63 | $1.90M | $610.3K | 8 | 2026-04-17 |
| Catalent, Inc. (CTLT) Delisted | Executive Chair | 0 | $63.48 | $0 | $1.54M | 10 | 2024-12-18 |
| CERNER Corp (CERN) Delisted | Director | 0 | $94.92 | $0 | $608.1K | 6 | 2022-06-09 |
| Hill-Rom Holdings, Inc. (HRC) Delisted | Chief Executive Officer | 230,851 | $155.96 | $36.00M | -$31.37M | 29 | 2017-12-15 |
| TomoTherapy Inc (TOMO) Delisted | Director | 0 | — | — | $0 | 3 | 2010-01-20 |
| BAX | Corporate Vice President | 86,868 | $23.00 | $2.00M | -$9.04M | 13 | 2009-03-18 |
Recent Filings · Page 6 of 7
69 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2010-05-12 | Hill-Rom Holdings, Inc. (HRC) Delisted | Buy (P) | +30,000 | $954.0K | EDGAR |
| 2010-04-01 | Hill-Rom Holdings, Inc. (HRC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2010-01-20 | TomoTherapy Inc (TOMO) Delisted | Disp (D) | −22,000 | $0 | EDGAR |
| 2010-01-12 | Hill-Rom Holdings, Inc. (HRC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2009-09-30 | TomoTherapy Inc (TOMO) Delisted | Grant (A) | +22,000 | $0 | EDGAR |
| 2009-03-18 | BAX | Tax (F) | −4,945 | -$252.5K | EDGAR |
| 2009-03-06 | BAX | Grant (A) | — | $0 | EDGAR |
| 2009-01-28 | BAX | Mixed | +6,000 | -$2.54M | EDGAR |
| 2008-06-02 | BAX | Grant (A) | +10,000 | $0 | EDGAR |
| 2008-05-29 | BAX | Sell (S) | −9,761 | -$586.7K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.